Skip to main content
S.C.P.C logo

S.C.P.C — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2024-11-07 Director's Dealing
Country TW Taiwan
Listing TW 1720

About S.C.P.C

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
113年10月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, managers, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a full financial report, earnings release, or meeting materials. The document is a report of personal share transactions and holdings by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document length is sufficient and contains substantive data on insider holdings, not just an announcement or certification.
2024-11-07 Chinese
113年10月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current holdings, pledged shares, and related party holdings. It is presented in a structured table format with no financial statements or narrative management discussion. The content focuses on insider shareholdings and related disclosures. This matches the definition of a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives. The document length is about 2598 characters, which is consistent with a detailed insider shareholding disclosure rather than a full financial report or announcement. There is no indication of an earnings release, annual report, or other financial report. Therefore, the appropriate classification is Director's Dealing (DIRS).
2024-11-07 Chinese
公告本公司民國113年第三季財務報告 董事會預計召開日期為113年11月08日
Regulatory Filings Classification · 95% confidence The document is a short announcement (553 characters) from a company (1720 生達) stating that the board meeting is scheduled for 113/11/08 to discuss the third quarter financial report for the year 113. It does not contain the actual financial report or detailed financial data but only announces the upcoming board meeting and the intention to present the quarterly financial report. According to the 'MENU VS MEAL' rule, this is an announcement about a report, not the report itself. Therefore, it should be classified as a Regulatory Filing (RNS), which is the fallback category for such announcements that do not contain substantive financial data.
2024-10-30 Chinese
113年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company providing details about fund lending balances and endorsement guarantees for the current and previous months, including limits and cumulative amounts. It is a regulatory disclosure of financial data related to intercompany and subsidiary transactions, but it is very short (613 characters) and does not contain comprehensive financial statements or analysis. It does not appear to be a full financial report like an Annual Report (10-K) or Interim Report (IR). It is also not an announcement of a meeting, voting results, or management changes. Given the nature of the data and the short length, this fits best as a Regulatory Filing (RNS), which is a general category for miscellaneous regulatory disclosures that do not fit other specific categories.
2024-10-09 Chinese
113年9月營業收入
Regulatory Filings Classification · 95% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 生達, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or comprehensive analysis. The length is short (773 characters), and it appears to be a regulatory disclosure of revenue figures rather than a full financial report. There is no indication that this is an announcement of a report publication or a certification. The content fits best with a Regulatory Filings (RNS) category, which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-10-09 Chinese
113年09月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, executives, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares for various insiders. This type of document is typical of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but contains substantive data on insider shareholdings. Therefore, the appropriate classification is Director's Dealing (DIRS).
2024-10-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.